| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 19.342 | 2.352 | 0 | 70.436 | 349.376 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 19.342 | 2.352 | 0 | 70.436 | 350.858 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 491 | 2.274 | 3.079 | 65.795 | 174.361 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 18.851 | 77 | -3.079 | 4.641 | 176.497 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 18.306 | 77 | -3.079 | 3.843 | 166.119 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 |
Check the financial reports for the company - Cretaterap Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 9.855 | 6.844 | 3.791 | 26.843 |
| Current Assets | 0 | 0 | 0 | 0 | -28 | 18.642 | 7.791 | 8.083 | 58.360 | 186.624 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 3.437 | 3.447 | -34 | 463 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 11.254 | 3.436 | 0 | 48.417 | 153.923 |
| Cash | 0 | 0 | 0 | 0 | -28 | 7.388 | 918 | 4.636 | 9.976 | 32.239 |
| Shareholders Funds | -369 | -365 | -359 | -352 | -346 | 17.967 | 17.646 | 14.586 | 18.393 | 166.167 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 369 | 365 | 359 | 353 | 317 | 676 | 0 | 341 | 43.757 | 47.299 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4322 - 4322" | |||||||||
| CAEN Financial Year |
4322
|
|||||||||
Comments - Cretaterap Srl